Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | erb-b2 receptor tyrosine kinase 4 | References | |
Homo sapiens | erb-b2 receptor tyrosine kinase 3 | Starlite/ChEMBL | References |
Homo sapiens | erb-b2 receptor tyrosine kinase 2 | References | |
Homo sapiens | epidermal growth factor receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | nuclear hormone receptor nor-1/nor-2 | 0.0022 | 0.0074 | 0.0087 |
Mycobacterium tuberculosis | Probable esterase/lipase LipP | 0.0084 | 0.0858 | 0.0414 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0106 | 0.1148 | 0.1327 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.0074 | 0.0041 |
Mycobacterium ulcerans | hypothetical protein | 0.0084 | 0.0858 | 1 |
Echinococcus granulosus | epidermal growth factor receptor | 0.068 | 0.849 | 1 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0534 | 0.663 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0277 | 0.3334 | 0.391 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0106 | 0.1148 | 0.1352 |
Mycobacterium tuberculosis | Probable lipase LipE | 0.0084 | 0.0858 | 0.0414 |
Mycobacterium leprae | Probable lipase LipE | 0.0084 | 0.0858 | 0.5 |
Echinococcus granulosus | tumor protein p63 | 0.0364 | 0.4446 | 0.5223 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-49 | 0.0022 | 0.0074 | 0.0041 |
Brugia malayi | Bromodomain containing protein | 0.0081 | 0.0829 | 0.0761 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0022 | 0.0074 | 0.0041 |
Schistosoma mansoni | tyrosine kinase | 0.0427 | 0.525 | 0.6183 |
Echinococcus multilocularis | COUP TF:Svp nuclear hormone receptor | 0.0022 | 0.0074 | 0.0058 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0022 | 0.0074 | 0.0058 |
Toxoplasma gondii | ABC1 family protein | 0.0084 | 0.0858 | 1 |
Echinococcus granulosus | geminin | 0.0182 | 0.2124 | 0.248 |
Schistosoma mansoni | FTZ-F1 nuclear receptor-like protein | 0.0022 | 0.0074 | 0.0087 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0018 | 0.0024 | 0.0029 |
Echinococcus multilocularis | geminin | 0.0182 | 0.2124 | 0.248 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0051 | 0.0436 | 0.0513 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0106 | 0.1148 | 0.1327 |
Schistosoma mansoni | hypothetical protein | 0.0022 | 0.0074 | 0.0087 |
Loa Loa (eye worm) | TAR-binding protein | 0.0277 | 0.3334 | 0.3312 |
Brugia malayi | TAR-binding protein | 0.0277 | 0.3334 | 0.3285 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.0074 | 0.0041 |
Echinococcus granulosus | zinc finger protein | 0.0021 | 0.0059 | 0.0041 |
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.043 | 0.5289 | 0.6219 |
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.0858 | 0.0828 |
Mycobacterium ulcerans | beta-lactamase | 0.0084 | 0.0858 | 1 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0214 | 0.2527 | 0.2957 |
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.0858 | 0.0828 |
Schistosoma mansoni | thyroid hormone receptor | 0.0022 | 0.0074 | 0.0087 |
Schistosoma mansoni | tyrosine kinase | 0.0427 | 0.525 | 0.6183 |
Echinococcus granulosus | COUP TF:Svp nuclear hormone receptor | 0.0022 | 0.0074 | 0.0058 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0084 | 0.0858 | 0.1011 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.032 | 0.0289 |
Schistosoma mansoni | tar DNA-binding protein | 0.0277 | 0.3334 | 0.3927 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0064 | 0.0609 | 0.0717 |
Schistosoma mansoni | hypothetical protein | 0.0182 | 0.2124 | 0.2501 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.068 | 0.849 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.043 | 0.5289 | 0.623 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0084 | 0.0858 | 0.1011 |
Mycobacterium tuberculosis | Conserved protein | 0.0084 | 0.0858 | 0.0414 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0084 | 0.0858 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0214 | 0.2527 | 0.2977 |
Brugia malayi | beta-lactamase family protein | 0.0084 | 0.0858 | 0.0791 |
Mycobacterium tuberculosis | Possible conserved lipoprotein LpqK | 0.0084 | 0.0858 | 0.0414 |
Mycobacterium tuberculosis | Probable conserved lipoprotein | 0.0084 | 0.0858 | 0.0414 |
Schistosoma mansoni | hypothetical protein | 0.0182 | 0.2124 | 0.2501 |
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.0858 | 0.0828 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.0022 | 0.0074 | 0.0087 |
Echinococcus granulosus | FTZ F1 nuclear receptor protein | 0.0022 | 0.0074 | 0.0058 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0106 | 0.1148 | 0.1327 |
Echinococcus granulosus | epidermal growth factor receptor | 0.043 | 0.5289 | 0.6219 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0084 | 0.0858 | 0.0985 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0277 | 0.3334 | 0.3312 |
Echinococcus multilocularis | Nuclear hormone receptor family member nhr 41 | 0.0022 | 0.0074 | 0.0058 |
Schistosoma mansoni | steroid hormone receptor ad4bp | 0.0022 | 0.0074 | 0.0087 |
Brugia malayi | Pre-SET motif family protein | 0.0032 | 0.0199 | 0.0126 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0084 | 0.0858 | 0.0828 |
Echinococcus granulosus | hepatocyte nuclear factor 4 alpha | 0.0022 | 0.0074 | 0.0058 |
Mycobacterium tuberculosis | Probable esterase LipL | 0.0084 | 0.0858 | 0.0414 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0051 | 0.0436 | 0.0486 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-41 | 0.0022 | 0.0074 | 0.0041 |
Echinococcus multilocularis | FTZ F1 alpha | 0.0022 | 0.0074 | 0.0058 |
Echinococcus multilocularis | FTZ F1 nuclear receptor protein | 0.0022 | 0.0074 | 0.0058 |
Schistosoma mansoni | bromodomain containing protein | 0.0069 | 0.0666 | 0.0785 |
Mycobacterium leprae | conserved hypothetical protein | 0.0084 | 0.0858 | 0.5 |
Echinococcus granulosus | FTZ F1 alpha | 0.0022 | 0.0074 | 0.0058 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0039 | 0.0287 | 0.031 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0065 | 0.0617 | 0.07 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0106 | 0.1148 | 0.1352 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.0022 | 0.0074 | 0.0058 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0084 | 0.0858 | 1 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.0022 | 0.0074 | 0.0058 |
Mycobacterium tuberculosis | Probable hydrolase | 0.0084 | 0.0858 | 0.0414 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0065 | 0.0617 | 0.07 |
Leishmania major | hypothetical protein, conserved | 0.0084 | 0.0858 | 1 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0224 | 0.2657 | 0.2633 |
Schistosoma mansoni | tyrosine kinase | 0.0214 | 0.2527 | 0.2977 |
Echinococcus multilocularis | ecdysone induced protein 78C | 0.0022 | 0.0074 | 0.0058 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0032 | 0.0199 | 0.0234 |
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.0858 | 0.0828 |
Schistosoma mansoni | coup transcription factor | 0.0022 | 0.0074 | 0.0087 |
Brugia malayi | beta-lactamase | 0.0084 | 0.0858 | 0.0791 |
Schistosoma mansoni | tyrosine kinase | 0.068 | 0.849 | 1 |
Mycobacterium tuberculosis | Conserved protein | 0.0084 | 0.0858 | 0.0414 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0106 | 0.1148 | 0.1119 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0106 | 0.1148 | 0.1082 |
Schistosoma mansoni | RAR-like nuclear receptor | 0.0022 | 0.0074 | 0.0087 |
Schistosoma mansoni | tyrosine kinase | 0.0427 | 0.525 | 0.6183 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0084 | 0.0858 | 0.0791 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0064 | 0.0609 | 0.7094 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.0074 | 0.0041 |
Schistosoma mansoni | tyrosine kinase | 0.043 | 0.5289 | 0.623 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0277 | 0.3334 | 0.3285 |
Schistosoma mansoni | tar DNA-binding protein | 0.0277 | 0.3334 | 0.3927 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.0022 | 0.0074 | 0.0058 |
Loa Loa (eye worm) | RNA binding protein | 0.0277 | 0.3334 | 0.3312 |
Onchocerca volvulus | 0.0255 | 0.3053 | 1 | |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-1 | 0.0022 | 0.0074 | 0.0041 |
Schistosoma mansoni | Tr4/Tr2 (homologue) | 0.0022 | 0.0074 | 0.0087 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.0074 | 0.0041 |
Onchocerca volvulus | 0.0084 | 0.0858 | 0.2634 | |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.0469 | 0.0438 |
Mycobacterium tuberculosis | Conserved protein | 0.0084 | 0.0858 | 0.0414 |
Echinococcus multilocularis | tar DNA binding protein | 0.0277 | 0.3334 | 0.391 |
Brugia malayi | Bromodomain containing protein | 0.0042 | 0.0319 | 0.0248 |
Schistosoma mansoni | nuclear hormone receptor | 0.0022 | 0.0074 | 0.0087 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0032 | 0.0199 | 0.0206 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0031 | 0.0184 | 0.0188 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0032 | 0.0199 | 0.0234 |
Mycobacterium ulcerans | lipase LipD | 0.0084 | 0.0858 | 1 |
Mycobacterium tuberculosis | Probable lipase LipD | 0.0084 | 0.0858 | 0.0414 |
Onchocerca volvulus | 0.0084 | 0.0858 | 0.2634 | |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0084 | 0.0858 | 1 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0084 | 0.0858 | 0.0985 |
Trichomonas vaginalis | set domain proteins, putative | 0.0255 | 0.3053 | 1 |
Onchocerca volvulus | 0.0032 | 0.0199 | 0.0421 | |
Echinococcus multilocularis | epidermal growth factor receptor | 0.043 | 0.5289 | 0.6219 |
Loa Loa (eye worm) | TK/INSR protein kinase | 0.0214 | 0.2527 | 0.2503 |
Loa Loa (eye worm) | nuclear Hormone Receptor family member | 0.0022 | 0.0074 | 0.0041 |
Echinococcus multilocularis | 0.0307 | 0.3713 | 0.4357 | |
Echinococcus granulosus | insulin receptor | 0.0214 | 0.2527 | 0.2957 |
Brugia malayi | Furin-like cysteine rich region family protein | 0.068 | 0.849 | 0.8479 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0064 | 0.0609 | 0.0691 |
Echinococcus granulosus | ecdysone induced protein 78C | 0.0022 | 0.0074 | 0.0058 |
Loa Loa (eye worm) | beta-lactamase | 0.0084 | 0.0858 | 0.0828 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.0074 | 0.0041 |
Echinococcus granulosus | Nuclear hormone receptor family member nhr 41 | 0.0022 | 0.0074 | 0.0058 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.068 | 0.849 | 0.8485 |
Brugia malayi | PHD-finger family protein | 0.0027 | 0.0134 | 0.006 |
Echinococcus multilocularis | hepatocyte nuclear factor 4 alpha | 0.0022 | 0.0074 | 0.0058 |
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.0858 | 0.0828 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0106 | 0.1148 | 0.1327 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0084 | 0.0858 | 1 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0064 | 0.0609 | 0.0691 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-31 | 0.0022 | 0.0074 | 0.0041 |
Loa Loa (eye worm) | steroid hormone receptor | 0.0022 | 0.0074 | 0.0041 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.0074 | 0.0041 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.0074 | 0.0041 |
Echinococcus multilocularis | tumor protein p63 | 0.0364 | 0.4446 | 0.5223 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0018 | 0.0024 | 0.0029 |
Brugia malayi | Protein kinase domain containing protein | 0.0214 | 0.2527 | 0.2472 |
Schistosoma mansoni | retinoid-x-receptor (RXR) | 0.0022 | 0.0074 | 0.0087 |
Brugia malayi | Pre-SET motif family protein | 0.0224 | 0.2657 | 0.2602 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.0436 | 0.0404 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-14 | 0.0022 | 0.0074 | 0.0041 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.077 | 0.0739 |
Echinococcus multilocularis | zinc finger protein | 0.0021 | 0.0059 | 0.0041 |
Schistosoma mansoni | tar DNA-binding protein | 0.0277 | 0.3334 | 0.3927 |
Onchocerca volvulus | 0.0084 | 0.0858 | 0.2634 | |
Brugia malayi | beta-lactamase family protein | 0.0084 | 0.0858 | 0.0791 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0084 | 0.0858 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.0858 | 0.0828 |
Plasmodium vivax | hypothetical protein, conserved | 0.0084 | 0.0858 | 1 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0024 | 0.0101 | 0.009 |
Schistosoma mansoni | photoreceptor-specific nuclear receptor related | 0.0022 | 0.0074 | 0.0087 |
Schistosoma mansoni | nuclear receptor 2DBD-gamma | 0.0022 | 0.0074 | 0.0087 |
Schistosoma mansoni | thyroid hormone receptor | 0.0022 | 0.0074 | 0.0087 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0051 | 0.0436 | 0.0513 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.0074 | 0.0041 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0053 | 0.0469 | 0.0553 |
Schistosoma mansoni | tar DNA-binding protein | 0.0277 | 0.3334 | 0.3927 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0064 | 0.0609 | 0.0717 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.0353 | 0.0322 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0214 | 0.2527 | 0.2957 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-40 | 0.0022 | 0.0074 | 0.0041 |
Brugia malayi | RNA binding protein | 0.0277 | 0.3334 | 0.3285 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0024 | 0.0101 | 0.0119 |
Echinococcus granulosus | retinoic acid receptor rxr beta a | 0.0022 | 0.0074 | 0.0058 |
Schistosoma mansoni | tar DNA-binding protein | 0.0277 | 0.3334 | 0.3927 |
Echinococcus multilocularis | insulin receptor | 0.0214 | 0.2527 | 0.2957 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0039 | 0.0287 | 0.031 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0051 | 0.0436 | 0.0486 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0798 | 1 | 1 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.0022 | 0.0074 | 0.0058 |
Onchocerca volvulus | 0.0053 | 0.0469 | 0.1328 | |
Schistosoma mansoni | zinc finger protein | 0.0021 | 0.0059 | 0.007 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0064 | 0.0609 | 0.6217 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0106 | 0.1148 | 0.1352 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.038 | 0.0348 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0024 | 0.0101 | 0.009 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | = -12 % | Inhibition of HER4 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 3 % | Inhibition of Lck at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 7 % | Inhibition of YES1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 10 % | Inhibition of RIPK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 12 % | Inhibition of PIM1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 14 % | Inhibition of MNK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 17 % | Inhibition of EPH-B3 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 18 % | Inhibition of PKD1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 18 % | Inhibition of SmMLCK at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 21 % | Inhibition of Aurora B at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 27 % | Inhibition of DYRK3 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 29 % | Inhibition of BRSK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 29 % | Inhibition of MKK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 32 % | Inhibition of PIM3 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 35 % | Inhibition of MINK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 37 % | Inhibition of FGF-R1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 37 % | Inhibition of PRK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 38 % | Inhibition of CHK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 39 % | Inhibition of NUAK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 44 % | Inhibition of Src at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 48 % | Inhibition of GCK at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 49 % | Inhibition of MELK at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 51 % | Inhibition of DYRK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 52 % | Inhibition of BRSK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 53 % | Inhibition of EPHA2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 57 % | Inhibition of CAMK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 62 % | Inhibition of PIM2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 63 % | Inhibition of p38alpha at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 63 % | Inhibition of CSK at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 64 % | Inhibition of PAK5 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 65 % | Inhibition of MLK3 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 65 % | Inhibition of DYRK1A at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 66 % | Inhibition of CK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 66 % | Inhibition of CAMKKbeta at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 66 % | Inhibition of Aurora A at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 67 % | Inhibition of SYK at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 70 % | Inhibition of IRR at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 72 % | Inhibition of JNK3 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 72 % | Inhibition of SGK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 72 % | Inhibition of RSK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 74 % | Inhibition of MARK4 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 75 % | Inhibition of PAK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 75 % | Inhibition of PBK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 75 % | Inhibition of S6K1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 76 % | Inhibition of JNK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 77 % | Inhibition of JNK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 77 % | Inhibition of NEK6 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 78 % | Inhibition of RSK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 78 % | Inhibition of PKCalpha at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 78 % | Inhibition of ERK8 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 79 % | Inhibition of BTK at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 79 % | Inhibition of p38delta at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 79 % | Inhibition of CHK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 79 % | Inhibition of His-IR at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 80 % | Inhibition of PKBbeta at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 81 % | Inhibition of p38beta at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 81 % | Inhibition of IRAK4 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 81 % | Inhibition of MAPKAPK-3 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 82 % | Inhibition of MARK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 83 % | Inhibition of PAK4 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 83 % | Inhibition of ERK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 85 % | Inhibition of p38-gamma at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 86 % | Inhibition of TTK at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 86 % | Inhibition of PKCzeta at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 86 % | Inhibition of MARK3 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 87 % | Inhibition of SRPK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 87 % | Inhibition of MLK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 88 % | Inhibition of PDK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 88 % | Inhibition of MST4 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 88 % | Inhibition of ERK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 89 % | Inhibition of PRAK at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 89 % | Inhibition of IKKepsilon at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 90 % | Inhibition of IKK-beta at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 90 % | Inhibition of MST2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 90 % | Inhibition of MAPKAP-K2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 91 % | Inhibition of EF2K at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 93 % | Inhibition of PAK6 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 93 % | Inhibition of CDK2/Cyclin A at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 93 % | Inhibition of MSK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 95 % | Inhibition of ROCK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 95 % | Inhibition of PLK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 96 % | Inhibition of GSK3-beta at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 96 % | Inhibition of NEK2a at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 97 % | Inhibition of HIPK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 103 % | Inhibition of LKB1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 103 % | Inhibition of PKBalpha at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 105 % | Inhibition of IGF-1R at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 106 % | Inhibition of HIPK3 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
Activity (binding) | = 126 % | Inhibition of HIPK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control | ChEMBL. | 20222733 |
IC50 (binding) | < 1 nM | Inhibition of EGFR Leu858Arg mutant by HTRF assay | ChEMBL. | 20222733 |
IC50 (binding) | < 1 nM | Inhibition of wild type EGFR by HTRF assay | ChEMBL. | 20222733 |
IC50 (binding) | = 190 nM | Inhibition of EGFR Leu858Arg and Thr790Met mutant by HTRF assay | ChEMBL. | 20222733 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.